glp-1 agonists reduce inflammation The anti-inflammatory and immunological properties of Receptor GLP-1 agonists' potential effects on

Description

Pursuant to 7 CFR 15.3, the University of Arkansas Division of Agriculture offers all its Extension and Research programs and services (including employment) without regard to race, color, sex, national origin, religion, age, disability, marital or veteran status, genetic information, sexual preference, pregnancy or any other legally protected status, and is an equal opportunity institution.

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

So, while Ozempic may (STILL) not have received the FDA's seal of approval for weight loss in non-diabetic patients, its hidden talent paved the way for Wegovy to step into the spotlight and take on a leading role in weight management

GLP-1RA Mechanism of Action GLP-1 (glucagon-like peptide-1) is a hormone secreted by the intestinal tract during feeding, which enhances insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, and delays gastric emptying to reduce the amount of food eaten through central appetite suppression